Critical Care and Respirology are common and interrelated practice areas for a significant number of pharmacotherapy specialists. These two areas are the focus of the latest book from the Pharmacotherapy Self-Assessment Program, Sixth Edition (PSAP-VI) series. Pulmonary and Critical Care provides an update on commonly encountered disorders in the field of respirology such as asthma, chronic obstructive pulmonary disease, pulmonary hypertension, and sleep apnea. The Critical Care section addresses common syndromes experienced by critically ill patients such as respiratory distress and endocrine and central nervous system syndromes. The pharmacotherapy of critically ill patient populations is discussed in chapters on Neurotrauma and Pediatric Burn. Finally, because critical care is resource-intensive, a chapter dedicated to health policy as it influences cost, quality, and safety in the ICU is provided. This book’s content is designed to assist pharmacists in performing the following procedures:

• Design a therapeutic plan consistent with the new National Institutes of Health guidelines for a patient with severe acute and/or chronic asthma;
• Develop and justify optimal therapy based on the current understanding of the pathophysiology of chronic obstructive pulmonary disease and available clinical evidence;
• Evaluate the treatment concepts involved in managing an acutely ill patient with pulmonary arterial hypertension;
• Design a treatment plan that optimizes non-pharmacological and pharmacological therapies for managing insomnia and sleep apnea;
• Evaluate the risks and benefits associated with the various treatment strategies for acute lung injury;
• Design effective strategies to optimize pharmacologically based ICU patient comfort while avoiding therapeutic misadventures;
• Analyze the biphasic neuroendocrine changes during critical illness and assess potential treatment strategies to correct neuroendocrine abnormalities;
• Develop a therapeutic plan for managing complications in patients with traumatic brain injury or spinal cord injuries;
• Develop a pharmacotherapy plan for a child with burns; and
• Assess the effect of critical care pharmacists and critical illness on outcomes.

Pulmonary and Critical Care will be released on April 15 as the sixth release in the 11-book PSAP-VI series. The book is available in both print and online formats. Continuing pharmacy education credit is available for those who successfully complete the self-assessment examinations provided with each module. The three modules offer a combined total of 20.5 hours of continuing pharmacy education credit. The sixth edition of PSAP features several improvements over previous editions, including all-online testing; answer books in PDF file format; shorter, more concise chapters; and expanded annotated bibliographies.

Other books in the PSAP-VI series include Cardiology; Nephrology; Neurology and Psychiatry; Science and Practice of Pharmacotherapy; Infectious Diseases; Women’s Health and Men’s Health; Health Promotion and Maintenance; Gastroenterology and Nutrition; Oncology; and Chronic Illnesses.

PSAP is dedicated to offering the most up-to-date and comprehensive information available regarding recent drug therapy advances. Each book will expand your knowledge in the therapeutic area covered. PSAP is priced as detailed (please note that shipping charges will apply):

For specific information pertaining to the release dates of future books, projected continuing education credits, and Accreditation Council for Pharmacy Education (ACPE) program numbers for each book, visit www.accp.com/p6_se.php, where you can quickly and conveniently place your order through the online bookstore. Use code BR0707 when ordering PSAP-VI.